内质网
肝硬化
对乙酰氨基酚
肝损伤
未折叠蛋白反应
调解人
内质网相关蛋白降解
细胞生物学
医学
癌症研究
生物
药理学
内科学
作者
Zhe Zhang,Xinyan Leng,Yuan Zhai,Xiao Zhang,Zhi Wei Sun,Jun Xiao,Jun Lu,Kun Liu,Bo Xia,Qi Gao,Miao Jia,Chengqi Xu,Yi Jiang,Xiaogang Zhang,Kaishan Tao,Jiangwei Wu
标识
DOI:10.1038/s41467-024-46135-9
摘要
Abstract Liver injury is a core pathological process in the majority of liver diseases, yet the genetic factors predisposing individuals to its initiation and progression remain poorly understood. Here we show that asialoglycoprotein receptor 1 (ASGR1), a lectin specifically expressed in the liver, is downregulated in patients with liver fibrosis or cirrhosis and male mice with liver injury. ASGR1 deficiency exacerbates while its overexpression mitigates acetaminophen-induced acute and CCl4-induced chronic liver injuries in male mice. Mechanistically, ASGR1 binds to an endoplasmic reticulum stress mediator GP73 and facilitates its lysosomal degradation. ASGR1 depletion increases circulating GP73 levels and promotes the interaction between GP73 and BIP to activate endoplasmic reticulum stress, leading to liver injury. Neutralization of GP73 not only attenuates ASGR1 deficiency-induced liver injuries but also improves survival in mice received a lethal dose of acetaminophen. Collectively, these findings identify ASGR1 as a potential genetic determinant of susceptibility to liver injury and propose it as a therapeutic target for the treatment of liver injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI